Article

Dr. Bimal Patel Discusses the Rising Costs of Generic Drugs

Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact's work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.

Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact’s work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.

Dr. Patel also discusses the importance of communication among pharmacy benefit managers, plan sponsors, and physicians as generic drug costs continue to rise.

Related Videos
Dr Gerard Criner
Emma Achola-Kothari, PhD
Dr Margrit Wiesendanger
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
2 experts in this video
Dr Emma Achola-Kothani
Marla Black Morgan, MD, Phoebe Neurology Associates
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo